Clinical Trials Browser

Diabetes Mellitus, Type 2

NCT06831994 2026-05-29

Digital Implementation of the German S3 Clinical Practice Guideline for Multimorbidity

Arthritis, Rheumatoid, Breast Neoplasms, Coronary Disease, Depression, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Heart Failure, Obesity, Osteoporosis, Pulmonary Disease, Chronic Obstructive

NCT07608055 2026-05-27

DCP-NDM

Not yet recruiting

579 enrolled

Gastrointestinal

Diabetes Mellitus, Type 2, Pancreatic Neoplasms

NCT07607912 2026-05-26

DCP-DM

Not yet recruiting

408 enrolled

Gastrointestinal

Diabetes Mellitus, Type 2, Pancreatic Neoplasms

NCT07595718 2026-05-19

AI-Based Phenome Data Analysis for Predicting the Onset of Major Diseases

Recruiting

1,000 enrolled

Breast

Breast Neoplasms, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Osteoarthritis, Low Back Pain

NCT04726319 2026-05-06

FHAMe

Phase NA Completed

627 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Coronary Artery Disease, Diabetes Mellitus, Type 2, Melanoma, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT07570667 2026-05-06

Global Longitudinal Health Monitoring and Blood Sample Collection Study to Promote Early-stage Disease Detection and Personalized/Precision Care Using Innovative Research Platforms

Not yet recruiting

15,000 enrolled

Diabetes Mellitus, Type 2, Hypertension, Neoplasms, Pulmonary Disease, Chronic Obstructive

NCT05950282 2026-05-01

DAISY

Recruiting

150 enrolled

Other

Diabetes Mellitus, Type 2, Hyperinsulinism, Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Metabolic Syndrome

NCT07513259 2026-04-07

Pre-Diagnosis GLP-1 Receptor Agonist Use and Post-Cancer Mortality in Adults With Obesity and Type 2 Diabetes

Completed

203,424 enrolled

Other

Diabetes Mellitus, Type 2, Neoplasms, Obesity, Overweight

NCT06803771 2026-03-23

SAFE-D

Phase NA Recruiting

15,000 enrolled

Gastrointestinal

Pancreatic cancer, adult, Diabetes Mellitus, Diabetes Mellitus, Type 2, Pancreatic Neoplasms

NCT07466212 2026-03-12

QoLIDia

Not yet recruiting

920 enrolled

Diabetes Mellitus, Type 2, Neoplasms

NCT07083154 2026-03-05

GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)

Phase 3 Recruiting

420 enrolled

Lymphoid

Dementia, Diabetes Mellitus, Type 2, Lymphoma, Follicular, Cognitive Dysfunction

Clinical Trials

Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings

Digital Implementation of the German S3 Clinical Practice Guideline for Multimorbidity

DCP-NDM

DCP-DM

AI-Based Phenome Data Analysis for Predicting the Onset of Major Diseases

FHAMe

Global Longitudinal Health Monitoring and Blood Sample Collection Study to Promote Early-stage Disease Detection and Personalized/Precision Care Using Innovative Research Platforms

DAISY

Pre-Diagnosis GLP-1 Receptor Agonist Use and Post-Cancer Mortality in Adults With Obesity and Type 2 Diabetes

SAFE-D

QoLIDia

GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)